sibrafiban ro proposed brand name xubix double prodrug platelet aggregation inhibitor developed secondary prevention arterial thrombosis following unstable angina pectoris acute myocardial infarction august hoffmannla roche announced preliminary results phase iii clinical trials shown sibrafiban better aspirin preventing recurrent ischemic events patients acute coronary syndrome development sibrafiban terminated drug article relating blood blood forming organs stub help wikipedia expanding httpsenwikipediaorgwikisibrafiban